Clinical investigationAspirin therapy: Optimized platelet inhibition with different loading and maintenance doses☆
References (31)
- et al.
Aspirin and platelets
Lancet
(1980) - et al.
Aspirin: a paradoxical effect on bleeding time
Lancet
(1978) - et al.
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veteran Administration cooperative study
N Engl J Med
(1983) Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
Lancet
(1990)- et al.
Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction
Thromb Haemost
(1985) - et al.
Acetylation of prostaglandin synthetase by aspirin
- et al.
Aspirin selectively inhibits prostaglandin production in human platelets
Nature
(1971) - et al.
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin
Br Med J
(1989) - et al.
Prophylaxis of aspirin induced gastric mucosal bleeding with ranitidine
Alimentary Pharmacol Ther
(1988) - et al.
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
J Clin Invest
(1983)
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
J Clin Invest
(1982)
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Nature
(1976)
Effect of Prostacyclin (PGX) on cyclic AMP concentrations in human platelets
Prostaglandins
(1977)
Clinical pharmacology of platelet cyclooxygenase inhibition
Circulation
(1985)
Aggregation of blood platelets by adenosine diphosphate and its reversal
Nature
(1962)
Cited by (0)
- ☆
Supported by the Deutsche Forschungsgemeinschaft, Bonn (grant DA 168/2-1).
Copyright © 1995 Published by Mosby, Inc.